| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.67 |
| Otolaryngology |
0 |
0.58 |
| Pain Management |
0 |
0.51 |
| Adolescent Medicine |
0 |
0.42 |
| Meta-Analysis |
0 |
0.18 |
| Severe Acute Respiratory Syndrome |
0 |
0.18 |
| Acute Respiratory Distress Syndrome |
0 |
0.16 |
| Otalgia |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Chest Pain |
0 |
0.12 |
| Abdominal Pain |
0 |
0.1 |
| Otitis Media |
0 |
0.1 |
| Angina Pectoris |
0 |
0.08 |
| Mood Swings |
0 |
0.08 |
| Skin Rash |
0 |
0.08 |
| Dermatitis |
0 |
0.06 |
| Anxiety |
0 |
0.05 |
| COVID-19 in Pediatrics |
0 |
0.98 |
| Fatigue |
0 |
0.05 |
| Fever |
0 |
0.05 |
| Quality of Life |
0 |
0.05 |
| Thorax |
0 |
0.05 |
| Anxiety Disorder |
0 |
0.04 |
| Conjunctivitis |
0 |
0.04 |
| Abdomen |
0 |
0.03 |
| Anosmia |
0 |
0.03 |
| Arrhythmia |
0 |
0.03 |
| Cough |
0 |
0.03 |
| Diversity |
0 |
0.03 |
| Dizziness |
0 |
0.03 |
| Dysphagia |
0 |
0.03 |
| Dysphonia |
0 |
0.03 |
| Dyspnea |
0 |
0.03 |
| Ear |
0 |
0.03 |
| Hair |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Hyperosmia |
0 |
0.03 |
| Hyposmia |
0 |
0.03 |
| Immunization |
0 |
0.03 |
| Memory |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Palpitations |
0 |
0.03 |
| Parosmia |
0 |
0.03 |
| Pharmacoepidemiology |
0 |
0.03 |
| Sleep |
0 |
0.03 |
| Tinnitus |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |
| Urticaria |
0 |
0.03 |
| Vertigo |
0 |
0.03 |
| Xeroderma |
0 |
0.03 |
| Constipation |
0 |
0.02 |
| Cornea and External Disease |
0 |
0.02 |
| Depression |
0 |
0.02 |
| Diarrhea |
0 |
0.02 |
| Dry Eye |
0 |
0.02 |
| Headache |
0 |
0.02 |
| Hyperhidrosis |
0 |
0.02 |
| Sleep Disorders |
0 |
0.02 |
| Social Determinants of Health |
0 |
0.02 |
| Urticaria and Angioedema |
0 |
0.02 |